Clinical trial
Endoscopic Ultrasound-guided Fine-needle Injection for Multiple Endocrine Neoplasia Type 1-related Pancreatic Neuroendocrine Tumors: a Prospective Multicenter Study
NCT05554744 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endoscopic Ultrasound-guided Fine-needle Injection for Multiple Endocrine Neoplasia Type 1-related Pancreatic Neuroendocrine Tumors: a Prospective Multicenter Study
- Lead sponsor
- Guangxi Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 18, 2015
- Completion date
- December 31, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple endocrine neoplasia type 1, pancreatic neuroendocrine tumor